Paras Healthcare Limited, which operates hospitals under the Paras Health brand, has raised ₹652.5 crore from anchor investors ahead of its initial public offering (IPO), scheduled to open for public subscription on October 21. The hospital chain allotted 94,15,584 equity shares to institutional investors at ₹693 per share, attracting participation from domestic mutual funds, global investment firms and insurance companies..

以“Paras Health”品牌运营医院的 Paras Healthcare Limited 在其定于10月21日开放公众认购的首次公开募股（IPO）之前，已从锚定投资者处筹集了65.25亿卢比。该医院连锁机构以每股693卢比的价格向机构投资者配售了9,415,584股普通股，吸引了国内共同基金、全球投资公司和保险公司的参与。

The anchor book drew investors including SBI Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mutual Fund, WhiteOak Capital, Abu Dhabi Investment Authority, BlackRock and Eastspring Investments. The participation reflects institutional investor interest in India’s organised hospital sector..

锚定投资者包括SBI共同基金、HDFC共同基金、ICICI保诚共同基金、Kotak共同基金、WhiteOak Capital、阿布扎比投资局、贝莱德和Eastspring Investments。这些机构的参与反映了机构投资者对印度规范化医院行业的兴趣。

Paras Healthcare’s IPO aims to raise ₹1,450 crore, comprising a fresh issue of shares worth ₹500 crore and an offer for sale (OFS) of ₹950 crore by existing shareholders. The price band is fixed at ₹660-₹693 per share, and the issue will close on October 23, 2026. The shares are tentatively scheduled to list on the BSE and NSE on October 28..

Paras Healthcare 的首次公开募股（IPO）计划募集资金 1,450 亿卢比，其中包括价值 500 亿卢比的新股发行，以及现有股东出售的价值 950 亿卢比的旧股。价格区间定为每股 660 至 693 卢比，申购将于 2026 年 10 月 23 日截止。股票暂定于 10 月 28 日在孟买证券交易所（BSE）和印度国家证券交易所（NSE）上市。

Of the fresh issue proceeds, the company plans to use a substantial portion to repay or prepay outstanding borrowings, with the remaining funds allocated to general corporate purposes and investment in its subsidiary, Plus Medicare Hospitals, which operates its Srinagar facility. The OFS will provide an exit opportunity for existing shareholders, including promoter Dharminder Kumar Nagar and investor Commelina Ltd..

就新股发行所得款项，公司计划将大部分用于偿还或提前偿还未偿借款，剩余资金则用于一般公司用途以及对其子公司Plus Medicare Hospitals的投资，该子公司负责运营其斯利那加设施。此次要约出售（OFS）将为现有股东（包括发起人Dharminder Kumar Nagar和投资者Commelina Ltd.）提供退出机会。

Paras Healthcare operates eight hospitals with a combined capacity of 2,211 beds across five states and one Union Territory. Its facilities are located in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand and Srinagar in Jammu and Kashmir..

Paras Healthcare 在五个邦和一个联邦属地运营着八家医院，总床位数为 2,211 张。其医疗机构分布在哈里亚纳邦的古尔冈和潘奇库拉、比哈尔邦的巴特那和达尔邦加、北方邦的坎普尔、拉贾斯坦邦的乌代浦尔、贾坎德邦的兰契以及查谟和克什米尔的斯利那加。

The company is planning further capacity expansion through a 300-bed hospital in Gurugram and a 500-bed facility in Ludhiana. These projects are expected to increase its total bed capacity to 3,011 by March 2028, subject to the planned development and commissioning schedules.

该公司计划通过在古尔冈建立一家拥有300张床位的医院以及在卢迪亚纳建立一家拥有500张床位的医疗设施，进一步扩大其产能。根据既定的开发和投产计划，这些项目预计将使该公司的总床位容量在2028年3月之前达到3,011张。

Paras Healthcare reported total income of approximately ₹1,629 crore in FY2025-26, up around 24% from ₹1,314 crore in the previous financial year. It also recorded a profit after tax of approximately ₹44 crore, compared with a loss of ₹58 crore in FY2024-25.

Paras Healthcare 在2025-26财年的总收入约为162.9亿卢比，较上一财年的131.4亿卢比增长约24%。该公司还录得税后利润约4.4亿卢比，而2024-25财年则为净亏损5.8亿卢比。

The IPO marks a significant capital-market milestone for Paras Healthcare as it seeks to strengthen its financial position and expand its hospital network. The use of fresh proceeds for debt repayment, alongside planned bed-capacity additions, will be key factors for investors assessing the company’s next phase of growth..

此次首次公开募股（IPO）标志着Paras Healthcare在资本市场上的重要里程碑，该公司正寻求强化其财务地位并扩大医院网络。将新募集资金用于偿还债务，以及计划增加病床容量，将是投资者评估公司下一阶段增长的关键因素。